Join the club for FREE to access the whole archive and other member benefits.

Johnson & Johnson unveil a new robotic platform 'Ottava'


Key points from article :

Johnson & Johnson’s surgical robotic platform Ottava offers unrivalled flexibility and control.

Designed with six arms, it has a zero-footprint design to enable patient access and improve workflow.

J&J’s new platform is called Ottava which mean 'an octave higher' in Italian.

“That (an octave higher) is what we mean to enable in medical intervention,” said Dr. Moll, J&J.

Verification and validation processes for Ottava will begin in 2021.

Followed by enrollment in clinical trials for the device in 2022.

“We view Ottava as the surgeon’s instrument for orchestrating a new level and elevating the surgical experience” - Dr. Moll

Plan to integrate it with their FDA approved Monarch robotic surgical system

Mentioned in this article:

Company Representative

CDO at Johnson & Johnson, known as "father of robotic surgery'